Researcher Next
Create account
← Back to directory

Bohuslav Melichar

Researcher Next ID · RN-009523

Researcher · Medicine

University Hospital Olomouc

, Czechia

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
794
Citation count
46,819
H-index
75
i10-index
314

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Renal cell carcinoma treatment
Cancer Immunotherapy and Biomarkers
HER2/EGFR in Cancer Research
Colorectal Cancer Treatments and Studies
Cancer Genomics and Diagnostics

Publications

  • Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    New England Journal of Medicine · 2019 · 10.1056/nejmoa1816714

  • Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    The Lancet · 2019 · 10.1016/s0140-6736(19)32591-7

  • Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1712126

  • Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

    The Lancet · 2013 · 10.1016/s0140-6736(13)61719-5

  • Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

    The Lancet · 2007 · 10.1016/s0140-6736(07)61904-7

Current projects

    No projects listed.